drugset / Trial / NCT01151605

The Suppression of Toll Like Receptors by Insulin

NCT01151605

Non-randomizedParallel-groupSingle-blindTreatment

Summary

This study will help us understand the possible beneficial effects of insulin in inflammation. Inflamamtion is considered to be the cause of atherosclerosis and heart disease.

Timeline

Start
2008-09
Primary completion
2013-09
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dextrose Unknown 12.5 %
Subject Insulin Protein / enzyme biologic 3.5 iu

Indications

No indication recorded.